Metraipolis › archive › dc_ca942775bbbb

Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach — Europe PMC PMID:42582333

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42582333
DOI: 10.3389/fphar.2026.1896516
License (as archived): solo-consultazione
Archived: 2026-10-08T15:46:02.236Z
SHA-256 of the archived text: 4bff652be14afee2114b922c6730f9329d30cb78ea8567180497f7b5366d2704
Stable URL of this page: https://metraipolis.com/documento/dc_ca942775bbbb

How to cite

Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach — Europe PMC PMID:42582333 — Europe PMC (en), https://europepmc.org/article/MED/42582333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca942775bbbb (Metraipolis archive dc_ca942775bbbb, sha256 4bff652be14afee2114b922c6730f9329d30cb78ea8567180497f7b5366d2704)

BibTeX

@misc{dcca942775bbbb,
  title = {Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach — Europe PMC PMID:42582333},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42582333},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca942775bbbb; sha256 4bff652be14afee2114b922c6730f9329d30cb78ea8567180497f7b5366d2704},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42582333. Agents can read the archived copy with the MCP tool read_document.